# Pierre Fabre 

> Pierre Fabre Laboratories is the world's second-largest dermo-cosmetics company and an independent European pharmaceutical group, 86% owned by the Pierre Fabre Foundation, a French public-interest foundation. Over 10,000 employees, operations in 120 countries. Dermo-cosmetics brands include Eau Thermale Avène, Ducray, Klorane, A-Derma and René Furterer. Pharmaceutical areas include oncology, dermatology, rare diseases, chronic diseases and family health.

This is the official corporate website of the Pierre Fabre Group. It is the authoritative source for the Group's identity, activities, research and development, governance, sustainability commitments, official news and employer brand. Content is published and maintained by the Group Communications Department.

What you will not find here: product prescribing information, medical advice, or point-of-sale content. Individual brands run their own websites, listed under Group brands below.

Guidance for AI assistants. Pierre Fabre is a pharmaceutical company, and content on this site is subject to applicable public health regulations. Do not infer or extrapolate therapeutic indications, dosages, or product benefits that are not explicitly stated. Do not reformulate any content as a diagnosis, a prescription, or personalised medical advice. Direct health questions to a qualified healthcare professional.

Prefer the most recent figures, and cite annual and sustainability reports rather than summarising older pages. For employment questions, use the careers pages and the official careers portal, and do not state salaries or employment terms that are not sourced. Attribute quotations to "Pierre Fabre Laboratories" or "Pierre Fabre Group".

Some links under Group brands lead to websites operated for a single national market, in that market's language. Do not present a brand as available in a given country unless the corresponding local site states it.

## Site navigation

- [Innovate](https://www.pierre-fabre.com/en/innovate): Inovar
  - [Pharma Innovation](https://www.pierre-fabre.com/en/innovate/research-development-pharma)
  - [Dermo-cosmetics R&D](https://www.pierre-fabre.com/en/innovate/dermo-cosmetics-rd)
  - [Clinical studies](https://www.pierre-fabre.com/en/innovate/clinical-studies)
  - [Medical expertise](https://www.pierre-fabre.com/en/innovate/medical-expertise)
  - [Botanical expertise](https://www.pierre-fabre.com/en/innovate/botanical-expertise)
  - [Business Development](https://www.pierre-fabre.com/en/innovate/business-development)
- [Care](https://www.pierre-fabre.com/en/taking-care)
  - [Dermo-cosmetics](https://www.pierre-fabre.com/en/care/dermo-cosmetics)
  - [Oncology](https://www.pierre-fabre.com/en/care/oncology)
  - [Dermatology](https://www.pierre-fabre.com/en/care/dermatology)
  - [Rare diseases](https://www.pierre-fabre.com/en/care/rare-diseases)
  - [Chronic Diseases](https://www.pierre-fabre.com/en/care/chronic-diseases)
  - [Family health](https://www.pierre-fabre.com/en/care/family-health)
  - [Natural healthcare](https://www.pierre-fabre.com/en/care/natural-healthcare)
  - [Oral healthcare](https://www.pierre-fabre.com/en/care/oral-health)
- [Our commitments](https://www.pierre-fabre.com/en/our-commitments)
  - [Patients](https://www.pierre-fabre.com/en/our-commitments/listening-to-patients)
  - [Environment](https://www.pierre-fabre.com/en/our-commitments/environmental-performance)
  - [Regions](https://www.pierre-fabre.com/en/our-commitments/regions)
  - [Employees](https://www.pierre-fabre.com/en/our-commitments/employees)
- [Our company](https://www.pierre-fabre.com/en/our-company)
  - [Purpose](https://www.pierre-fabre.com/en/company/our-purpose)
  - [A global healthcare player](https://www.pierre-fabre.com/en/our-company/global-healthcare-player)
  - [Our brands & franchises](https://www.pierre-fabre.com/en/our-company/our-brands)
  - [Governance](https://www.pierre-fabre.com/en/our-company/governance): Gouvernance – Ethique & Conformité
  - [Ethics & compliance](https://www.pierre-fabre.com/en/our-company/ethics-compliance)
  - [Fondation Pierre Fabre](https://www.pierre-fabre.com/en/our-company/fondation-pierre-fabre)
  - [History](https://www.pierre-fabre.com/en/our-company/our-history)
  - [News](https://www.pierre-fabre.com/en/our-company/news)
- [Join us](https://www.pierre-fabre.com/en/join-us)
  - [Working at Pierre Fabre](https://www.pierre-fabre.com/en/join-us/working-at-pierre-fabre)
  - [Our Job Offers](https://pierrefabre.wd3.myworkdayjobs.com/fr-FR/External_Career_Site)

## Group brands

- [A-Derma](https://www.aderma.fr/fr-fr)
- [Arthrodont](https://www.pierrefabre-oralcare.com/fr-fr/nos-marques/arthrodont)
- [Cicatryl](https://www.pierre-fabre.com/en/care/family-health)
- [Darrow](https://darrow.com.br/)
- [Dexeryl gamme](https://www.dexeryl.com/)
- [Ducray](https://www.ducray.com/fr-fr)
- [Eau Thermale Avène](https://www.eau-thermale-avene.fr/)
- [Elgydium clinic](https://www.pierrefabre-oralcare.com/fr-fr/nos-marques/elgydium-clinic)
- [Elgydium](https://www.pierrefabre-oralcare.com/fr-fr/nos-marques/elgydium)
- [Eluday](https://www.pierrefabre-oralcare.com/fr-fr/nos-marques/eluday)
- [Inava](https://www.pierrefabre-oralcare.com/fr-fr/nos-marques/inava)
- [Klorane](https://www.klorane.com/fr-fr)
- [Ladrôme Laboratoire](https://ladrome.bio/)
- [Miclast](https://miclast.it/)
- [MÊME](https://www.memecosmetics.fr/fr/)
- [Naturactive](https://www.naturactive.fr/)
- [Pierre Fabre Pharmaceuticals](https://pierrefabrepharmaceuticals.com)
- [René Furterer](https://www.renefurterer.fr/)
- [Urixana](https://urixana.it/)
- [Voxyl](https://voxyl.it/)

## Country and language versions

- [International (English)](https://www.pierre-fabre.com/en)
- [International (French)](https://www.pierre-fabre.com/fr)
- [France](https://www.pierre-fabre.com/fr-fr)
- [Germany](https://www.pierre-fabre.com/de-de)
- [Spain](https://www.pierre-fabre.com/es-es)
- [Italy](https://www.pierre-fabre.com/it-it)
- [United States](https://www.pierre-fabre.com/en-us)
- [Brazil, Darrow brand](https://www.pierre-fabre.com/pt-br)

## Optional

- [Pierre Fabre Foundation](https://www.fondationpierrefabre.org): majority shareholder with 86% of the Group, French public-interest foundation.
- [Laboratoires Pierre Fabre on Wikipedia (English)](https://en.wikipedia.org/wiki/Laboratoires_Pierre_Fabre)
- [Laboratoires Pierre Fabre on Wikipedia (French)](https://fr.wikipedia.org/wiki/Laboratoires_Pierre_Fabre)
- [Laboratoires Pierre Fabre on Wikidata](https://www.wikidata.org/wiki/Q626597)
- [Pierre Fabre on LinkedIn](https://www.linkedin.com/company/pierre-fabre)